Drugplain

NEOPROFEN 10 mg/mL

ibuprofen lysine · SOLUTION · Recordati Rare Diseases Inc.

No Recall History
Plain English

NEOPROFEN is a solution containing ibuprofen lysine at 10 mg/mL, taken intravenous. Manufactured by Recordati Rare Diseases Inc..

Key Facts

Brand Name
NEOPROFEN
Generic Name
ibuprofen lysine
NDC Code (Product)
55292-122
Manufacturer
Recordati Rare Diseases Inc.
Strength
10 mg/mL
Dosage Form
SOLUTION
Route
INTRAVENOUS
Marketing Status
Application #
NDA021903
Marketing Start
04/13/2006

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

bronchopulmonary dysplasia113 reports
intraventricular haemorrhage34 reports
necrotising colitis30 reports
gastrointestinal perforation29 reports
completed suicide27 reports
anaemia25 reports
hyponatraemia25 reports
intestinal perforation25 reports
urine output decreased23 reports
death20 reports

Frequently Asked Questions

What is NEOPROFEN used for?

NEOPROFEN contains ibuprofen lysine. It is a solution taken intravenous. Consult your doctor for specific uses.

Is NEOPROFEN a controlled substance?

NEOPROFEN is not classified as a controlled substance by the DEA.

What is the generic name for NEOPROFEN?

The generic name for NEOPROFEN is ibuprofen lysine. There are 2 other brand versions of ibuprofen lysine.

What is the NDC code for NEOPROFEN 10 mg/mL?

The NDC (National Drug Code) for NEOPROFEN 10 mg/mL is 55292-122, listed by Recordati Rare Diseases Inc..

Product NDC

55292-122

Package NDC

55292-122-52

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)